Neuronetics (STIM) Non-Current Deffered Revenue (2017 - 2026)
Neuronetics' (STIM) quarterly Non-Current Deffered Revenue came in at $58000.0 in Q1 2026, up 20.83% on a QoQ basis from $48000.0 in Q4 2025.
Neuronetics (STIM) Non-Current Deffered Revenue (2017 - 2026) Analysis & Trends
Neuronetics (STIM) has 10 years of Non-Current Deffered Revenue data on file, last reported at $58000.0 in Q1 2026.
- On a quarterly basis, Non-Current Deffered Revenue changed N/A year-over-year to $58000.0 in Q1 2026; TTM through Mar 2026 was $58000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $48000.0, up 2300.0% from the prior year.
- Non-Current Deffered Revenue for Q1 2026 stood at $58000.0, up from $48000.0 in the prior quarter.
- Over the last five years, Non-Current Deffered Revenue for STIM reached as high as $1.3 million in Q1 2022 and fell as low as $2000.0 in Q4 2024.
- Historically, Non-Current Deffered Revenue has averaged $440357.1 across 5 years, with a median of $277000.0 in 2023.
- Across the five-year window, Non-Current Deffered Revenue sank 99.0% in 2024 and soared 2300.0% in 2025, its largest moves.
- Year by year, Non-Current Deffered Revenue stood at $829000.0 in 2022, then plunged by 75.87% to $200000.0 in 2023, then sank by 99.0% to $2000.0 in 2024, then surged by 2300.0% to $48000.0 in 2025, then gained by 20.83% to $58000.0 in 2026.
- Per Business Quant data, the three most recent Non-Current Deffered Revenue figures were $58000.0 in Q1 2026, $48000.0 in Q4 2025, and $2000.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 512.79 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Neuronetics | 130.83 Mn | 128.62 Mn | 16.15 Mn | 58,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 58,000.00 |
| Dec 31, 2025 | 48,000.00 |
| Dec 31, 2024 | 2,000.00 |
| Sep 30, 2024 | 4,000.00 |
| Jun 30, 2024 | 15,000.00 |
| Mar 31, 2024 | 35,000.00 |
| Dec 31, 2023 | 200,000.00 |
| Sep 30, 2023 | 354,000.00 |
| Jun 30, 2023 | 513,000.00 |
| Mar 31, 2023 | 671,000.00 |
| Dec 31, 2022 | 829,000.00 |
| Sep 30, 2022 | 981,000.00 |
| Jun 30, 2022 | 1.13 Mn |
| Mar 31, 2022 | 1.33 Mn |
| Dec 31, 2021 | 1.47 Mn |
| Sep 30, 2021 | 1.36 Mn |
| Jun 30, 2021 | 1.49 Mn |
| Mar 31, 2021 | 1.61 Mn |
| Dec 31, 2020 | 1.74 Mn |
| Sep 30, 2020 | 1.86 Mn |